F. V. van Loon

发表

Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up.

D. Sack, J. Chakraborty, J. Clemens, 1996, Vaccine.

Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines.

D. Sack, J. Harris, J. Chakraborty, 1990, Vaccine.

Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems.

V. Dietz, A. Galazka, S. Cochi, 1997, Bulletin of the World Health Organization.

Varicella in Americans from NHANES III: Implications for control through routine immunization

P. Kilgore, M. Wharton, D. Kruszon-Moran, 2003, Journal of medical virology.

Sociodemographic, hygienic and nutritional correlates of Helicobacter pylori infection of young Bangladeshi children.

F. Qadri, J. Clemens, M. Albert, 1996, The Pediatric infectious disease journal.

Double blind trial of loperamide for treating acute watery diarrhoea in expatriates in Bangladesh.

M. Bennish, P. Speelman, F. V. van Loon, 1989, Gut.

Case report of Plesiomonas shigelloides-associated persistent dysentery and pseudomembranous colitis

B. Kay, Z. Rahim, F. V. van Loon, 1989, Journal of Clinical Microbiology.

Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus.

V. Dietz, S. Cochi, J. Milstien, 1996, Bulletin of the World Health Organization.

Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.

D. Sack, J. Chakraborty, J. Clemens, 1995, American journal of epidemiology.

Breast feeding and the risk of severe cholera in rural Bangladeshi children.

D. Sack, J. Harris, J. Chakraborty, 1990, American Journal of Epidemiology.

Perfusion studies in cholera: methods and procedures.

K. Gyr, F. V. van Loon, A. Banik, 1992, Journal of diarrhoeal diseases research.

Gastric emptying of oral rehydration solutions in acute cholera.

A. Molla, A. Molla, N. Alam, 1989, The Journal of tropical medicine and hygiene.

Rubella seropositivity in the United States, 1988-1994.

D. Kruszon-Moran, G. Mcquillan, B. Forghani, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rotavirus-associated diarrhea in rural Bangladesh: two-year study of incidence and serotype distribution

S. Tzipori, J. Clemens, L. Unicomb, 1991, Journal of clinical microbiology.

Impact of infection by Helicobacter pylori on the risk and severity of endemic cholera.

R. Sack, F. Qadri, J. Clemens, 1995, The Journal of infectious diseases.

The effect of L-glutamine on salt and water absorption: a jejunal perfusion study in cholera in humans.

D. Mahalanabis, D. Darmaun, M. Wahed, 1996, European journal of gastroenterology & hepatology.

Indomethacin decreases jejunal fluid secretion in addition to luminal release of prostaglandin E2 in patients with acute cholera.

J. Rask-Madsen, Van Loon, G. Rabbani, 1992, Gut.

Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test.

D. Sack, J. Clemens, M. Rao, 1990, Journal of clinical epidemiology.

Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody.

D. Sack, R. Ward, J. Clemens, 1992, The Journal of infectious diseases.

Mumps surveillance--United States, 1988-1993.

M. Lindegren, S. Cochi, W. Williams, 1995, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

ABO blood groups and the risk of diarrhea due to enterotoxigenic Escherichia coli.

D. Sack, J. Harris, J. Chakraborty, 1991, The Journal of infectious diseases.

Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh.

D. Sack, R. Ward, J. Clemens, 1992, The Journal of infectious diseases.